WallStSmart

Monster Beverage Corp (MNST)vs22nd Century Group Inc (XXII)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Monster Beverage Corp generates 178389% more annual revenue ($9.22B vs $5.17M). MNST leads profitability with a 23.1% profit margin vs -76.0%. MNST earns a higher WallStSmart Score of 64/100 (C+).

MNST

Buy

64

out of 100

Grade: C+

Growth: 7.3Profit: 9.0Value: 5.3Quality: 7.8
Piotroski: 4/9Altman Z: 6.29

XXII

Avoid

31

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 6.7Quality: 6.5
Piotroski: 4/9Altman Z: -20.53
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MNSTUndervalued (+67.4%)

Margin of Safety

+67.4%

Fair Value

$146.42

Current Price

$47.81

$98.61 discount

UndervaluedFair: $146.42Overvalued
XXIIUndervalued (+52.8%)

Margin of Safety

+52.8%

Fair Value

$11.90

Current Price

$3.04

$8.86 discount

UndervaluedFair: $11.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MNST6 strengths · Avg: 8.8/10
Altman Z-ScoreHealth
6.2910/10

Safe zone — low bankruptcy risk

Market CapQuality
$89.18B9/10

Large-cap with strong market position

Return on EquityProfitability
22.7%9/10

Every $100 of equity generates 23 in profit

Profit MarginProfitability
23.1%9/10

Keeps 23 of every $100 in revenue as profit

Operating MarginProfitability
29.2%8/10

Strong operational efficiency at 29.2%

Revenue GrowthGrowth
20.2%8/10

Revenue surging 20.2% year-over-year

XXII2 strengths · Avg: 10.0/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0710/10

Conservative balance sheet, low leverage

Areas to Watch

MNST3 concerns · Avg: 2.7/10
Price/BookValuation
10.0x4/10

Trading at 10.0x book value

PEG RatioValuation
2.742/10

Expensive relative to growth rate

P/E RatioValuation
42.1x2/10

Premium valuation, high expectations priced in

XXII4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$2.68M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-103.6%2/10

ROE of -103.6% — below average capital efficiency

Revenue GrowthGrowth
-40.4%2/10

Revenue declined 40.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : MNST

The strongest argument for MNST centers on Altman Z-Score, Market Cap, Return on Equity. Profitability is solid with margins at 23.1% and operating margin at 29.2%. Revenue growth of 20.2% demonstrates continued momentum.

Bull Case : XXII

The strongest argument for XXII centers on Price/Book, Debt/Equity.

Bear Case : MNST

The primary concerns for MNST are Price/Book, PEG Ratio, P/E Ratio. A P/E of 42.1x leaves little room for execution misses.

Bear Case : XXII

The primary concerns for XXII are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

MNST profiles as a growth stock while XXII is a turnaround play — different risk/reward profiles.

XXII carries more volatility with a beta of 0.60 — expect wider price swings.

MNST is growing revenue faster at 20.2% — sustainability is the question.

MNST generates stronger free cash flow (461M), providing more financial flexibility.

Bottom Line

MNST scores higher overall (64/100 vs 31/100), backed by strong 23.1% margins and 20.2% revenue growth. XXII offers better value entry with a 52.8% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Monster Beverage Corp

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Monster Beverage Corporation is an American beverage company that manufactures energy drinks including Monster Energy, Relentless and Burn.

Visit Website →

22nd Century Group Inc

CONSUMER DEFENSIVE · TOBACCO · USA

22nd Century Group Inc (Ticker: XXII) is an innovative biopharmaceutical and agricultural leader dedicated to tobacco harm reduction through advanced genetic engineering. The company specializes in the development of low-nicotine tobacco products aimed at reducing nicotine addiction and enhancing public health. Additionally, 22nd Century is strategically diversifying into the burgeoning hemp and cannabis markets, aligning itself with the rapid growth of the legal cannabis sector. By prioritizing scientific research and regulatory compliance, 22nd Century presents a compelling investment opportunity for institutional investors interested in transformative, socially responsible sectors.

Want to dig deeper into these stocks?